Clincosm LogoSign in Get a demo

B-cell Leukemia

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-Cell Leukemia, B-Cell Lymphoma, B-cell Tumors Trial in Kunming (Anti-CD19 Autologous CAR-T Cell Infusion)

Recruiting
  • B-Cell Leukemia
  • +2 more
  • Anti-CD19 Autologous CAR-T Cell Infusion
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Jul 9, 2023

B-cell Lymphoma, B-cell Leukemia Trial in Kunming (anti-CD19 UCAR-NK cells)

Withdrawn
  • B-cell Lymphoma
  • B-cell Leukemia
  • anti-CD19 UCAR-NK cells
  • Kunming, Yunnan, China
    Kunming Hope of Health Hospital
Nov 27, 2022

Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Acute Lymphoid Leukemia
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia Trial (KUR-502)

Not yet recruiting
  • NHL, Relapsed, Adult
  • +3 more
  • KUR-502
  • (no location specified)
Aug 2, 2022

B-Cell Leukemia, B Cell Lymphoma Trial in Kunming (anti-CD19 UCAR-T injection)

Recruiting
  • B-Cell Leukemia
  • B Cell Lymphoma
  • anti-CD19 UCAR-T injection
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Apr 21, 2022

B-cell Leukemia Trial in Sanhe (CD19/CD20 Dual-CAR-T cells)

Completed
  • B-cell Leukemia
  • CD19/CD20 Dual-CAR-T cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Mar 6, 2022

B-cell Leukemia, B-Cell Lymphoma Trial in Uppsala (CAR T cells)

Completed
  • B-cell Leukemia
  • B-Cell Lymphoma
  • CAR T cells
  • Uppsala, Sweden
    Uppsala University Hospital, Dept of Oncology
Oct 14, 2021

B-Cell Leukemia, B-Cell Lymphoma Trial in Guangzhou (4SCAR19/22 T cells, Interleukin-2)

Suspended
  • B-Cell Leukemia
  • B-Cell Lymphoma
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Aug 9, 2021

B-cell Leukemia Trial in Guangzhou, Shenzhen, Shijiazhuang (4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR)

Recruiting
  • B-cell Leukemia
  • 4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR
  • Guangzhou, Guangdong, China
  • +2 more
Sep 18, 2019

B-Cell Leukemia, B-Cell Lymphoma Trial in Shijiazhuang (Autologous CD19-targeting CAR T cells)

Unknown status
  • B-Cell Leukemia
  • B-Cell Lymphoma
  • Autologous CD19-targeting CAR T cells
  • Shijiazhuang, Hebei, China
    No.2 Hospital of Hebei Medical University
Apr 27, 2017

Leukemia, B-cell Leukemia, Chronic Leukemia Trial in Stanford (Alemtuzumab, Fludarabine, Cytoxan)

Completed
Has Results
  • Leukemia
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Sep 25, 2014

B-Cell Lymphoma, B-Cell Leukemia Trial in United States (PCI-32765)

Completed
  • B-Cell Lymphoma
  • B-Cell Leukemia
  • Palo Alto, California
  • +8 more
May 21, 2013